Proposal 1:To elect the nine directors nominated to the Board of Directors of the Company and named in the Proxy Statement, each for a one-year term ending in 2026. Proposal 2:To approve, by ...
SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill ...
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which the transaction applies: (2) Aggregate number of securities to which the ...
Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to Execute Strategic Plan Urges ...
Outlines Attributes of Carronade’s Four Independent and Highly Qualified Director Nominees and Why They Are Best-Suited to Create Value DARIEN, Conn., April 07, 2025 (GLOBE NEWSWIRE) -- Carronade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results